(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202503 | 202403 | % Var | 202503 | 202403 | % Var | 202503 | 202403 | % Var | |
| Sales | 27319.90 | 28940.30 | -5.60 | 109333.00 | 106456.40 | 2.70 | 109333.00 | 106456.40 | 2.70 |
| Other Income | 1139.80 | 1229.70 | -7.31 | 3281.20 | 6160.60 | -46.74 | 3281.20 | 6160.60 | -46.74 |
| PBIDT | 7104.90 | 8977.60 | -20.86 | 28856.90 | 28401.00 | 1.61 | 28856.90 | 28401.00 | 1.61 |
| Interest | 610.90 | 530.70 | 15.11 | 2300.40 | 1826.00 | 25.98 | 2300.40 | 1826.00 | 25.98 |
| PBDT | 6494.00 | 8446.90 | -23.12 | 26556.50 | 26575.00 | -0.07 | 26556.50 | 26575.00 | -0.07 |
| Depreciation | 938.80 | 648.10 | 44.85 | 2972.00 | 2545.80 | 16.74 | 2972.00 | 2545.80 | 16.74 |
| PBT | 5555.20 | 7798.80 | -28.77 | 23584.50 | 24029.20 | -1.85 | 23584.50 | 24029.20 | -1.85 |
| TAX | 1473.50 | 2012.10 | -26.77 | 6116.60 | 5028.20 | 21.65 | 6116.60 | 5028.20 | 21.65 |
| Deferred Tax | -79.00 | -64.50 | 22.48 | -157.10 | -952.60 | -83.51 | -157.10 | -952.60 | -83.51 |
| PAT | 4081.70 | 5786.70 | -29.46 | 17467.90 | 19001.00 | -8.07 | 17467.90 | 19001.00 | -8.07 |
| Equity | 580.80 | 585.90 | -0.87 | 580.80 | 585.90 | -0.87 | 580.80 | 585.90 | -0.87 |
| PBIDTM(%) | 26.01 | 31.02 | -16.17 | 26.39 | 26.68 | -1.07 | 26.39 | 26.68 | -1.07 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: